Product Description:
Baricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. Baricitinib may be used as monotherapy or in combination with Methotrexate.
Product Features:
| Product Name | : | Baricinix |
| Generic Name | : | Baricitinib |
| Formulation | : | Tablet |
| Available Pack Size | : | 30’s Pot |
| Available Strength | : | 2mg & 4mg |
| Registrations | : | Export Only |
| Website | : | Baricinix.com |
